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Epigenetic states are responsive to developmental and environmental signals, and as a conse-
quence a eukaryotic cell can have many different epigenomes. In this issue of Cell, Lister et al. 
(2008) present the floral epigenome of Arabidopsis using next-generation sequencing technology 
to analyze both DNA methylation at single-base resolution and the expression of small RNAs.In eukaryotic cells, gene activity is con-
trolled not only by DNA sequences but also 
by epigenetic marks, which can be trans-
mitted to a cell’s progeny during mitosis or 
meiosis. Although epigenetic regulation is 
generally mediated by histone modifica-
tions, histone variants, and DNA cytosine 
methylation, it also involves the production 
and action of noncoding RNAs, particularly 
small RNAs (Bernstein et al., 2007; Huet-
tel et al., 2006; Henderson and Jacobsen, 
2007). An essential step in understanding 
epigenetic regulation is to have genome-
wide, high-resolution maps of these epige-
netic features. Just as the study of genet-
ics has been revolutionized by the ability 
to sequence entire eukaryotic genomes, 
next-generation sequencing technologies 
are now making it possible to determine 
the genome-wide distributions of methy-
lated DNA, histone variants, and histone 
modifications. In short, epigenomes can 
now be sequenced. In this issue, Ecker 
and colleagues (Lister et al., 2008) present 
a genome-wide map of DNA methylation 
at single-base resolution in developing 
floral tissue of the model plant Arabidop-
sis. Integrating this map with an analysis 
of the floral transcriptome and small RNA 
profiles reveals new insights into the global 
interplay of DNA methylation, small RNAs, 
and transcription.Lister and colleagues used bisulfite 
sequencing to determine the methy-
lome of Arabidopsis floral tissues. In 
a complementary paper in Nature, 
Jacobsen and coworkers (Cokus et al., 
2008) independently used the same 
technology to sequence the methy-
lome of adult Arabidopsis plants. Like 
previous studies that mapped methy-
lation in Arabidopsis using microarrays 
(Zhang et al., 2006; Zilberman et al., 
2007), these new studies find exten-
sive DNA methylation throughout the 
genome. They show that methylation 
is high in heterochromatic regions, 
dispersed in euchromatic regions, 
and prevalent in the body of genes. 
The mapping of DNA methylation at 
single-base resolution also reveals 
that local sequence context has a 
strong effect on cytosine methylation. 
The results have important implica-
tions for clarifying the mechanisms 
of action and characteristics of DNA 
methyltransferase enzymes, and also 
contribute to a better understanding 
of the evolution of gene promoters and 
other regulatory sequences.
Both of the new studies compared 
the methylomes of wild-type plants to 
those of plants lacking individual DNA 
methyltransferases (DNMTs). De novo Cemethylation in Arabidopsis is carried 
out by the methyltransferases DRM1 
and DRM2, which are orthologs of the 
DNMT3 family in mammals. In contrast, 
maintenance of CG and CHG (where H 
is C, T, or A) methylation is mediated by 
the DNMT1-like enzyme MET1 and the 
plant-specific enzyme CMT3, respec-
tively (Henderson and Jacobsen, 2007). 
Because it is presumed that asymmetric 
CHH methylation cannot be maintained 
during DNA replication (Huettel et al., 
2006), the de novo methyltransferases 
DRM1 and DRM2 are expected to be 
the main (or sole) enzymes responsible 
for CHH methylation. The new stud-
ies, however, show that met1 and cmt3 
loss-of-function mutations have even 
greater effects in reducing the overall 
level of CHH methylation in the genome 
than does the loss of both drm1 and 
drm2. This result suggests that MET1 
and CMT3 may also be important for 
de novo methylation at many genomic 
regions (Figure 1). In addition, mainte-
nance of methylation at CG and CHG 
sites may be required for efficient CHH 
methylation by DRM1 and DRM2.
Lister et al. also sequenced the tran-
scriptome of Arabidopsis floral tis-
sues, including an extensive analysis 
of small RNA populations. Comparing ll 133, May 2, 2008 ©2008 Elsevier Inc. 395
this information with the DNA methy-
lome revealed that sequences match-
ing small RNAs are 25 times more likely 
to be methylated than sequences with-
out small RNA matches. This striking 
correlation between small RNAs and 
DNA methylation supports the notion 
that RNA-directed DNA methylation 
occurs genome wide (Huettel et al., 
2006). RNA-directed DNA methyla-
tion was first discovered in plants 
more than a decade ago and involves 
a pathway that generates 24 nucle-
otide small RNAs that are then bound 
to Argonaute 4 (AGO4). RNA-directed 
DNA methylation requires the chroma-
tin remodeling factor DRD1 and DRM1/
DRM2 to direct the methylation of cor-
responding genomic DNA (Huettel et 
al., 2006) (Figure 1). Interestingly, Lister 
et al. found a tendency for the sense 
strand (relative to the small RNA) to 
be methylated. An attractive model to 
explain strand-specific methylation is 
that nascent transcripts from the sense 
strand may hybridize with the small 
RNAs, thus bringing the effector com-
plex for RNA-directed DNA methylation 
to the sense strand for methylation.
Yet small RNAs are associated with 
only one-third of methylated loci (Lister 
et al., 2008). Thus, the remaining two-
thirds of genomic cytosine methyla-
tion must be directed by mechanisms 
that are independent of small RNAs 
(Figure 1). Some small RNA-indepen-
dent methylation corresponds to gene 
body methylation (where methylation 
is concentrated within the gene rather 
than at the ends of a gene). The func-
tion of gene body methylation remains 
enigmatic because its loss in the met1 
mutant does not substantially affect 
transcript levels (Zhang et al., 2006; 
Lister et al., 2008). However, loss of 
gene body CG methylation in the met1 
mutant is often compensated for by an 
increase in CHG methylation (Cokus et 
al., 2008; Lister et al., 2008), suggest-
ing that maintaining gene body methy-
lation is important. Perhaps gene body 
methylation helps to inhibit cryptic 
transcription initiation (Zilberman et al., 
2007). Alternatively, it might suppress 
recombination or transposon insertion 
within genes. For small RNA-indepen-
dent DNA methylation, DNA methyl-
transferase enzymes may be directed 
to the target sequences by specific 
histone modifications or by chromatin 
remodeling.
Although DNA methylation is a 
relatively stable epigenetic modifica-
tion, it can be very dynamic and is 
subject to active demethylation (Zhu 
et al., 2007). In principle, patterns of 
DNA methylation can result from the 
targeted action of methyltransferases 
Figure 1. DNA Methyltransferases and Demethylases in Arabidopsis
DNA methyltransferases can be targeted by both small RNA-dependent and RNA-independent pathways 
to achieve methylation at CG or non-CG sites. For some loci, DNA demethylases actively remove methy-
lation to prevent silencing. Small RNA production is controlled by DNA methylation in a self-reinforcing 
positive feedback loop. The dotted line indicates the possibility that small RNAs may direct heterochro-
matic histone modifications.396 Cell 133, May 2, 2008 ©2008 Elsevier Inc.or indiscriminate methyltransferase 
activity that is later reset or trimmed 
by demethylases (or a combination of 
these two mechanisms). Whereas the 
identities of DNA demethylases remain 
elusive in mammals, in Arabidopsis 
ROS1 and related DNA glycosylases 
function as locus-specific demethy-
lases through a base-excision repair 
pathway (Gong et al., 2002; Zhu et al., 
2007; Penterman et al., 2007). Lister et 
al. sequenced the floral DNA methy-
lome and transcriptome in a mutant 
deficient in the demethylases. They 
found hundreds of discrete regions 
with increased DNA methylation in this 
mutant, further supporting a crucial 
role of the demethylases in pruning 
DNA methylation in transposons and 
other loci and thereby upholding their 
expression levels (Zhu et al., 2007). 
Intriguingly, the methylation levels at 
some other sites were decreased in 
the demethylase mutant. This result 
suggests that these large DNA glyco-
sylase proteins with potential chro-
matin-interaction domains may be 
important for maintaining DNA methy-
lation at some sites. Alternatively, the 
expression of some DNA methyltrans-
ferase genes may be reduced in the 
demethylase mutant as a compensa-
tory response to hypermethylation 
at certain critical sites. Huettel et al. 
(2006) reported that in met1 and other 
mutants with DNA hypomethylation, 
ROS1 gene expression is significantly 
reduced. With these kinds of compen-
satory responses in mind, it is clear 
that not all of the altered DNA methy-
lation patterns in the met1 mutant can 
be attributed directly to MET1 enzyme 
activity.
The pioneering work of Lister et al. 
and Cokus et al. provides valuable 
snapshots of portions of the epige-
nomes of Arabidopsis. The transcrip-
tomes of an organism are continually 
changing in response to developmen-
tal and environmental cues. Similarly, 
the epigenome is not static and can 
be molded by developmental signals, 
environmental perturbations, and dis-
ease states. Therefore, many epig-
enomes will need to be sequenced for 
a single organism, making epigenome 
sequencing perhaps even more chal-
lenging than genome sequencing.
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Neurons are of course not the only 
excitable cells in the body—heart cells 
are also excitable. In the heart, CaM-
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idant cellular environment produced in 
many other forms of cardiac dysfunc-
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and reperfusion after anoxia all induce 
the production of ROS through activa-
tion of NADPH oxidase. In addition, a 
diverse collection of agents, including 
angiotensin II, induce translocation 
of the NADPH oxidase subunit p47 to 
the cell membrane. This change in p47 
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